Pharma

Your Article Summary

See Latest Articles

Medtronic and Abbott Laboratories Resolve Global Vascular Patent Disputes
Medtronic, 07/28/09

Medtronic, Inc. announced global resolution of all outstanding intellectual property litigation with Abbott Laboratories. Terms of the agreement stipulate that neither party will sue each other in the field of coronary stent and stent delivery systems for a period of at least 10 years, subject to certain conditions. The agreement includes a $400 million settlement payment to be made to Abbott and also results in a $42 million success payment to evYsio Medical Devices, LLC, as part of a Medtronic sublicense to Abbott of the evYsio stent design technology.

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

Omnicell Gets Cabinet Deal in Carolinas
HealthDataManagement, 12/16/09

Array BioPharma and Amgen Partner in Type 2 Diabetes
Amgen, 12/15/09

Inno Biologics and CEVEC Sign License Agreement for Human CAP Technology
b3c newswire, 12/09/09

 See all of M&A/Partnerships